PACT - Public Activities Coordination Tool

PACT - Public Activities Coordination Tool

PACT - Public Activities Coordination Tool

The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.

PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:

  • Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
  • Assessment of regulatory needs (ARN).
  • Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.

A summary of all the substance-specific activities can be found under ‘Details’ for each entry.

Filter the list
Latest update:
Process:

The List does not contain any Substances.
Data generation and assessment ARN Regulatory risk management
 
Lithium hydroxide 215-183-4 1310-65-2 - - 1 - 2 - - - - Details
Lithium isooctadecanoate 283-815-6 84731-55-5 - - 1 - - - - - - Details
Lithium myristate 243-743-8 20336-96-3 - - 1 - - - - - - Details
Lithium naphthalene-2-carboxylate 700-040-5 674347-28-5 - - 1 - - - - - - Details
Lithium Nickel Cobalt Aluminium Oxide 700-042-6 177997-13-6 - - 1 - - - - - - Details
Lithium phosphorodifluoridate 643-080-8 24389-25-1 - - 1 - 1 - - - - Details
lithium sodium 2-amino-4-{[4-(cyanoazanidyl)-6-[(3-sulfonatophenyl)amino]-1,3,5-triazin-2-yl]amino}-5-(2-{4-[2-(sulfonatooxy)ethanesulfonyl]phenyl}diazen-1-yl)benzene-1-sulfonate 413-090-5 - - - 1 - - - - - - Details
Lithium stearate 224-772-5 4485-12-5 - - 1 - - - - - - Details
Lithium tetrafluoroborate, anhydrous 238-178-9 14283-07-9 - - 1 - - - - - - Details
Lithium, sodium 2-(4-chloro-6-cyanoamino-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(2-methoxy-5-(sulfatoethanesulfonyl)phenylazo)naphthalene-1,7-disulfonate 440-050-4 - - - 1 - 1 - - - - Details
Lysine hydrochloride 211-519-9 657-27-2 - - 1 - - - - - - Details
m-phenylene di(acetate) 203-596-2 108-58-7 - - 1 - - - - - - Details
m-phenylenediamine 203-584-7 108-45-2 1 - 1 - - - - - - Details
m-TDI oligomers, isocyanurate 938-708-5 - - - 1 - 1 - - - - Details
m-tolylidene diisocyanate 247-722-4 26471-62-5 1 - 1 - 2 - - - - Details
Magnesium bis(2-ethylbutanoate) 700-021-1 79992-76-0 - - 1 - 1 - - - - Details
Magnesium bis(2-ethylbutanoate) 421-140-2 - - - 1 - 1 - - - - Details
Magnesium carbonate 208-915-9 546-93-0 - - 1 - - - - - - Details
Magnesium dihydrogen disulphite 237-403-8 13774-25-9 - - 1 - - - - - - Details
Magnesium hydroxide sulphate trihydrate 483-390-9 12508-61-1 - - 1 - - - - - - Details
Magnesium sulphate 231-298-2 7487-88-9 - - 1 - - - - - - Details
Maleic acid 203-742-5 110-16-7 - - 1 - - - - - - Details
Malononitrile 203-703-2 109-77-3 - - 1 - 1 - - - - Details
Man-made vitreous (silicate) fibres with random orientation with alkaline and alkali earth oxides (Na2O+K2O+CaO+ MgO+BaO) content greater than 18% by weight and fulfilling one of the CLP Regulation Annex VI Note Q conditions 926-099-9 - - - 1 - - - - - - Details
Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+ MgO+BaO) content greater than 18 % by weight 924-055-3 - - - 1 - - - - - - Details
Manganate(1-), glycinato-N,O)[sulfato(2-)-O]-, hydrogen 838-538-0 52139-31-8 - - 1 - - - - - - Details
Manganese bis(dihydrogen phosphate) 242-520-2 18718-07-5 - - 1 - 1 - - - - Details
Manganese di(acetate) 211-334-3 638-38-0 - - 1 - 1 - - - - Details
Manganese neodecanoate 248-374-6 27253-32-3 - - 1 - 1 - - - - Details
Manganese oxalate 211-367-3 640-67-5 - - 1 - 1 - - - - Details
Manganese sulphate 232-089-9 7785-87-7 - - 1 - 3 - - - - Details
Menthane, monohydroperoxy derivative 247-987-6 26762-92-5 - - 1 - 1 - - - - Details
Mercaptoacetic acid, monoester with propane-1,2,3-triol 250-264-8 30618-84-9 - - 1 - - - - - - Details
Methacrylic acid 201-204-4 79-41-4 - - 1 - 1 - - - - Details
Methansulfonic acid (1,6-hexanediyl-diimino)bis[1-oxo, disodium salt 690-526-2 38632-47-2 - - 1 - 1 - - - - Details
Methyl (S)-(-)-lactate 248-704-9 27871-49-4 - - 1 - - - - - - Details
Methyl 3-oxo-2-pentylcyclopentaneacetate 246-495-9 24851-98-7 - - 1 - - - - - - Details
Methyl 3-α,7-α-diacetoxy-12-oxo-5-β-cholan-24-oate 249-070-6 28535-81-1 - - 1 - - - - - - Details
Methyl 3-α,7-α-diacetoxy-12-α-hydroxy-5-β-cholan-24-oate 223-151-6 3749-87-9 - - 1 - - - - - - Details
Methyl 4-[[(2,5-dichlorophenyl)amino]carbonyl]-2-[[2-hydroxy-3-[[(2-methoxyphenyl)amino]carbonyl]-1-naphthyl]azo]benzoate 263-272-1 61847-48-1 - - 1 - - - - - - Details
Methyl 4-cyano-5-[[5-cyano-2,6-bis[(3-methoxypropyl)amino]-4-methyl-3-pyridyl]azo]-3-methyl-2-thenoate 277-146-9 72968-71-9 - - 1 - - - - - - Details
Methyl 5-(dimethylamino)-2-methyl-5-oxopentanoate 700-204-6 1174627-68-9 - - 1 - - - - - - Details
Methyl 5-nitrohydrogen.isophthalate 217-793-6 1955-46-0 - - 1 - 1 - - - - Details
Methyl [3-(trimethoxysilyl)propyl]carbamate 245-659-7 23432-62-4 - - 1 - - - - - - Details
Methyl benzoylformate 239-263-3 15206-55-0 - - 1 - 1 - - - - Details
Methyl dec-9-enoate 662-772-0 25601-41-6 - - 1 - 1 - - - - Details
Methyl dodec-9-enoate 700-618-7 39202-17-0 - - 1 - 1 - - - - Details
Methyl formate 203-481-7 107-31-3 - - 1 - - - - - - Details
Methyl isothiocyanate 209-132-5 556-61-6 - - 1 - - 1 - - - Details
Methyl salicylate 204-317-7 119-36-8 1 - 1 1 1 1 - - - Details

Export search results to: